US FDA finds “significant violations” at India’s Strides plant Reuters Jul 17, 2019 The drugmaker was caught trying to dispose quality-control records, the FDA said in a letter made public on July 16
Mylan rejects Teva’s $40 bn offer as ‘gross undervaluation’ Usha Sharma Apr 28, 2015 Says, "bringing Teva's 'dysfunctional' culture to the region (India) could disrupt the core of its business, result in the flight…
